Gilead Sciences Inc (GILD)

Santiago
Currency in USD
Disclaimer
65.55
0.00(0.00%)
Closed

GILD Comments

Good job GILD. bullish move forward
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
Up Again
Time to load up before the big rise coming next week
Classic pump n’ dump. What a shambles
Will reach above 95
when? hahah
Good time to accumulate.
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
High chance to be trading above 90, good long stock
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
Gilead has ebola medical called remdesivir, currently seems to be successfull also in treating covid, final study should be available end of March
not if they dont find a vaccine. it will be condidered a waste of time and money and the stock will drop.
gild and regn is working out on covid19 vaccine. both price getting higher as they promise to work it out. they will boom once they found the vaccine
buy position lets go profit by jordan